Fig 1.
Percentage increase in total and adjusted costs of care from breast cancer diagnosis until death for extreme users of disease-monitoring testing. Adjusted for costs of disease-monitoring testing, including serum tumor-marker tests and radiographic imaging and analyzed by using natural log transformation by multivariable linear regression adjusted for characteristics displayed in Table 1 (20 participants not included due to no cost data). P < .001 for all values.